1995
DOI: 10.1016/0006-8993(94)01265-j
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
36
0

Year Published

1995
1995
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(39 citation statements)
references
References 50 publications
3
36
0
Order By: Relevance
“…In agreement with pronociception, after long-term intrathecal administration of NPY, or a Y1 but not a Y2 agonist, nerve injury-induced hyperalgesia was exacerbated (White, 1997), and there is a Y1 receptor-dependent enhancement of calcium influx in vagal sensory neurons (Wiley et al, 1993). Moreover, subcutaneous injection of NPY, Y1R, or Y2R agonists increased mechanical hyperalgesia, although the application of Y1R agonists relieved thermal hyperalgesia (Tracey et al, 1995). Also, NPY, when acting on peripheral Y2Rs, was shown to be an important player in the sympathetically dependent neurogenic inflammation induced by intradermal capsaicin in rats (Lin et al, 2004).…”
Section: Npyergic Mechanisms and Painsupporting
confidence: 67%
“…In agreement with pronociception, after long-term intrathecal administration of NPY, or a Y1 but not a Y2 agonist, nerve injury-induced hyperalgesia was exacerbated (White, 1997), and there is a Y1 receptor-dependent enhancement of calcium influx in vagal sensory neurons (Wiley et al, 1993). Moreover, subcutaneous injection of NPY, Y1R, or Y2R agonists increased mechanical hyperalgesia, although the application of Y1R agonists relieved thermal hyperalgesia (Tracey et al, 1995). Also, NPY, when acting on peripheral Y2Rs, was shown to be an important player in the sympathetically dependent neurogenic inflammation induced by intradermal capsaicin in rats (Lin et al, 2004).…”
Section: Npyergic Mechanisms and Painsupporting
confidence: 67%
“…Clinical and experimental studies revealed that sympathetic modulation plays a critical role under conditions of neuropathy or neurogenic inflammation in peripheral nerves or tissues (Green et al 1993;Kim and Chung 1991;Lin et al 2003Moon et al 1999;Ren et al 2005a;Xie et al 1995) by a mechanism of sympathetic-sensory interactions in DRG neurons (Chung et al 1996;Devor et al 1994), the site of nerve injury (Devor and Seltzer 1999), and the skin (Sato and Perl 1991). The release of adrenergic and/or nonadrenergic transmitters is suggested to be the mechanism underlying the interactions because these substances have been well documented to play roles in nociception (Dowd et al 1998;Drummond 1995Drummond , 1998Lee et al 1999;Tracey et al 1995). Critically, these substances were shown to be colocalized in the synaptic vesicles of the postganglionic sympathetic nerve terminals and coreleased into the extracellular space to participate in several pathophysiological processes, including pathological pain signaling (Abbracchio and Burnstock 1998;Burnstock 1990Burnstock , 1996Park et al 2000;Sneddon et al 1996).…”
Section: Discussionmentioning
confidence: 99%
“…The functional significance of an increase in ''prejunctional'' receptors or sympathetic neurons after Axo is unclear. NPY has been shown to contribute to peripheral hyperalgesia by acting on prejunctional Y2Rs on postganglionic sympathetic terminals (38), which could be present at high levels on sympathetic fibers regenerating after Axo.…”
Section: Discussionmentioning
confidence: 99%